Amicus Therapeutics spins off genetic medicine unit in $600M SPAC deal
September 29, 2021 at 15:02 PM EDT
Amicus is spinning off part of its gene therapy business a year after establishing its gene therapy research center in Philadelphia.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.